Prothena plc (PRTA) Touches $40.15 Formed H&S; Ceva (CEVA) Sentiment Is 0.93

Prothena Corporation plc (NASDAQ:PRTA) Logo

Ceva Inc (CEVA) investors sentiment decreased to 0.93 in Q4 2017. It’s down -0.98, from 1.91 in 2017Q3. The ratio worsened, as 65 active investment managers increased or opened new equity positions, while 70 decreased and sold equity positions in Ceva Inc. The active investment managers in our database now own: 18.39 million shares, up from 18.23 million shares in 2017Q3. Also, the number of active investment managers holding Ceva Inc in top ten equity positions was flat from 4 to 4 for the same number . Sold All: 22 Reduced: 48 Increased: 44 New Position: 21.

Prothena Corporation plc (PRTA) formed inverse H&S with $41.35 target or 3.00% above today’s $40.15 share price. Prothena Corporation plc (PRTA) has $1.55B valuation. The stock decreased 9.18% or $4.06 during the last trading session, reaching $40.15. About 672,767 shares traded or 18.74% up from the average. Prothena Corporation plc (NASDAQ:PRTA) has declined 31.00% since April 6, 2017 and is downtrending. It has underperformed by 42.55% the S&P500.

Oaktop Capital Management Ii L.P. holds 6.9% of its portfolio in CEVA, Inc. for 743,836 shares. Awm Investment Company Inc. owns 712,558 shares or 6.38% of their US portfolio. Moreover, Herald Investment Management Ltd has 4.61% invested in the company for 318,382 shares. The Illinois-based Oberweis Asset Management Inc has invested 2.04% in the stock. Ranger Investment Management L.P., a Texas-based fund reported 602,256 shares.

The stock decreased 0.81% or $0.3 during the last trading session, reaching $36.55. About 99,401 shares traded. CEVA, Inc. (CEVA) has risen 3.29% since April 6, 2017 and is uptrending. It has underperformed by 8.26% the S&P500.

Analysts await CEVA, Inc. (NASDAQ:CEVA) to report earnings on May, 3. They expect $0.03 earnings per share, down 85.00% or $0.17 from last year’s $0.2 per share. CEVA’s profit will be $666,582 for 304.58 P/E if the $0.03 EPS becomes a reality. After $0.15 actual earnings per share reported by CEVA, Inc. for the previous quarter, Wall Street now forecasts -80.00% negative EPS growth.

CEVA, Inc. licenses signal processing intellectual property technologies to semiconductor companies and original equipment manufacturers (OEMs) serving the mobile, consumer, automotive, industrial, and Internet-of Things (IoT) markets worldwide. The company has market cap of $812.12 million. The firm licenses a family of programmable digital signal processor (DSP) cores and application-specific platforms for vision, imaging, and audio and voice, as well as long and short range wireless technologies, Wi-Fi, Bluetooth IPs, Serial ATA, and Serial Attached SCSI. It has a 48.73 P/E ratio. The Company’s technologies are licensed to semiconductor and OEM companies in the form of IP, which is used for the design, manufacture, market, and sale of application-specific integrated circuits and application-specific standard products to wireless, consumer electronics, and automotive companies for incorporation into a variety of end products.

Since January 1, 0001, it had 0 insider buys, and 2 sales for $129,432 activity.

Investors sentiment decreased to 1.18 in Q4 2017. Its down 0.47, from 1.65 in 2017Q3. It is negative, as 29 investors sold Prothena Corporation plc shares while 32 reduced holdings. 28 funds opened positions while 44 raised stakes. 31.32 million shares or 0.27% more from 31.24 million shares in 2017Q3 were reported. Sandy Spring Bank reported 0% stake. Moreover, Granite Point Mngmt Lp has 0.11% invested in Prothena Corporation plc (NASDAQ:PRTA) for 30,000 shares. Ny State Common Retirement Fund stated it has 0% of its portfolio in Prothena Corporation plc (NASDAQ:PRTA). Meeder Asset Inc stated it has 108 shares. Morgan Stanley holds 156,519 shares or 0% of its portfolio. Envestnet Asset Management reported 108 shares stake. Sei Investments holds 5,030 shares or 0% of its portfolio. Blackrock Inc holds 0.01% or 2.97 million shares in its portfolio. Jennison Associate Ltd Liability Co accumulated 416,031 shares. Pnc Fincl Svcs Grp Inc Incorporated holds 0% or 5,384 shares in its portfolio. Employees Retirement Association Of Colorado reported 0% of its portfolio in Prothena Corporation plc (NASDAQ:PRTA). Teacher Retirement System Of Texas holds 12,830 shares. Pointstate Cap L P owns 245,890 shares. Kistler has 0% invested in Prothena Corporation plc (NASDAQ:PRTA). World reported 0.01% of its portfolio in Prothena Corporation plc (NASDAQ:PRTA).

Among 14 analysts covering Prothena Corp (NASDAQ:PRTA), 13 have Buy rating, 0 Sell and 1 Hold. Therefore 93% are positive. Prothena Corp has $100 highest and $60 lowest target. $76.60’s average target is 90.78% above currents $40.15 stock price. Prothena Corp had 32 analyst reports since July 22, 2015 according to SRatingsIntel. Deutsche Bank maintained Prothena Corporation plc (NASDAQ:PRTA) on Monday, October 23 with “Buy” rating. As per Friday, May 13, the company rating was initiated by Barclays Capital. Suntrust Robinson initiated it with “Buy” rating and $75 target in Wednesday, December 21 report. The rating was maintained by Wedbush on Friday, February 19 with “Outperform”. The stock has “Buy” rating by Cantor Fitzgerald on Wednesday, December 20. The rating was maintained by Wedbush with “Outperform” on Tuesday, August 4. Credit Suisse initiated the stock with “Outperform” rating in Thursday, January 21 report. As per Thursday, February 15, the company rating was maintained by Cantor Fitzgerald. On Monday, November 20 the stock rating was downgraded by Wedbush to “Neutral”. As per Thursday, September 28, the company rating was maintained by Cantor Fitzgerald.

CEVA, Inc. (NASDAQ:CEVA) Institutional Positions Chart